M3B Fundamental Analysis - PYRAMID AG

Fundamental Rating

M3B gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 30 industry peers in the Technology Hardware, Storage & Peripherals industry. M3B may be in some trouble as it scores bad on both profitability and health. M3B is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year M3B has reported negative net income.

The reported net income has been mixed in the past 5 years: M3B reported negative net income in multiple years.

M3B had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

M3B has a Return On Assets of -0.29%. This is in the lower half of the industry: M3B underperforms 63.33% of its industry peers.

With a Return On Equity value of -0.48%, M3B perfoms like the industry average, outperforming 50.00% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-0.29%
ROE	-0.48%
ROIC	N/A

ROA(3y)2.26%

ROA(5y)-2.19%

ROE(3y)3.1%

ROE(5y)-2.17%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of -434.35%, M3B is doing worse than 93.33% of the companies in the same industry.

M3B's Gross Margin has declined in the last couple of years.

M3B does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	-434.35%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-13.41%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for M3B has been increased compared to 1 year ago.

The number of shares outstanding for M3B has been increased compared to 5 years ago.

The debt/assets ratio for M3B is higher compared to a year ago.

2.2 Solvency

M3B has an Altman-Z score of 0.31. This is a bad value and indicates that M3B is not financially healthy and even has some risk of bankruptcy.

M3B has a Altman-Z score of 0.31. This is in the lower half of the industry: M3B underperforms 70.00% of its industry peers.

A Debt/Equity ratio of 0.28 indicates that M3B is not too dependend on debt financing.

M3B has a better Debt to Equity ratio (0.28) than 66.67% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Altman-Z	0.31

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

M3B has a Current Ratio of 2.94. This indicates that M3B is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 2.94, M3B belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.

A Quick Ratio of 1.08 indicates that M3B should not have too much problems paying its short term obligations.

Looking at the Quick ratio, with a value of 1.08, M3B is in line with its industry, outperforming 56.67% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.94
Quick Ratio	1.08

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

M3B shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -150.00%.

Looking at the last year, M3B shows a very negative growth in Revenue. The Revenue has decreased by -115.30% in the last year.

Measured over the past years, M3B shows a very strong growth in Revenue. The Revenue has been growing by 143.51% on average per year.

EPS 1Y (TTM)-150%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-450%

Revenue 1Y (TTM)-115.3%

Revenue growth 3Y441.32%

Revenue growth 5Y143.51%

Sales Q2Q%-19.28%

3.2 Future

M3B is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 37.15% yearly.

Based on estimates for the next years, M3B will show a quite strong growth in Revenue. The Revenue will grow by 14.84% on average per year.

EPS Next Y-140%

EPS Next 2Y100%

EPS Next 3Y68.69%

EPS Next 5Y37.15%

Revenue Next Year10.57%

Revenue Next 2Y17.03%

Revenue Next 3Y17.22%

Revenue Next 5Y14.84%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

M3B reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for M3B. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as M3B's earnings are expected to grow with 68.69% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y100%

EPS Next 3Y68.69%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for M3B!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

PYRAMID AG

FRA:M3B (1/5/2026, 7:00:00 PM)

0.854

-0.01 (-0.7%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryTechnology Hardware, Storage & Peripherals

Earnings (Last)11-14 2025-11-14

Earnings (Next)02-18 2026-02-18

Inst Owners2.11%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap19.70M

Revenue(TTM)-5.99M

Net Income(TTM)-211.00K

Analysts80

Price Target1.68 (96.72%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.45
P/tB	1.51
EV/EBITDA	N/A

EPS(TTM)-0.02

EYN/A

EPS(NY)-0.06

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS-0.26

BVpS1.89

TBVpS0.56

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.29%
ROE	-0.48%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	-434.35%
FCFM	N/A

ROA(3y)2.26%

ROA(5y)-2.19%

ROE(3y)3.1%

ROE(5y)-2.17%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-13.41%

F-ScoreN/A

Asset Turnover-0.08

Health

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.94
Quick Ratio	1.08
Altman-Z	0.31

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-150%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-450%

EPS Next Y-140%

EPS Next 2Y100%

EPS Next 3Y68.69%

EPS Next 5Y37.15%

Revenue 1Y (TTM)-115.3%

Revenue growth 3Y441.32%

Revenue growth 5Y143.51%

Sales Q2Q%-19.28%

Revenue Next Year10.57%

Revenue Next 2Y17.03%

Revenue Next 3Y17.22%

Revenue Next 5Y14.84%

EBIT growth 1Y-350.05%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year294.18%

EBIT Next 3Y98.02%

EBIT Next 5Y54.74%

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

PYRAMID AG / M3B.DE FAQ

Can you provide the ChartMill fundamental rating for PYRAMID AG?

ChartMill assigns a fundamental rating of 2 / 10 to M3B.DE.

What is the valuation status for M3B stock?

ChartMill assigns a valuation rating of 1 / 10 to PYRAMID AG (M3B.DE). This can be considered as Overvalued.

What is the profitability of M3B stock?

PYRAMID AG (M3B.DE) has a profitability rating of 1 / 10.

PYRAMID AG (M3B.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

PYRAMID AG / M3B.DE FAQ

Can you provide the ChartMill fundamental rating for PYRAMID AG?

What is the valuation status for M3B stock?

What is the profitability of M3B stock?